Skip to main content

Articles


Nov 10, 2015
István Gábor Takács
In Slovakia, the cost/benefit analysis carried out on a needle and syringe exchange program showed that every euro invested in C.A. Odyseus´s harm reduction program generated benefits worth almost three euros. Read what the figures show about why it’s worthwhile investing in harm reduction!

Nov 4, 2015
Péter Sárosi
Ohio voters did not reject the legal regulation of cannabis – they only rejected one particular form of legalisation. We think they were wise to do so.

Oct 26, 2015
István Gábor Takács
The Drugreporter filmed some of the key sessions at the Harm Reduction Conference in Kuala Lumpur, Malaysia.

Oct 21, 2015
Péter Sárosi
The Drugreporter video team attended and filmed the International Harm Reduction Conference to learn about the new trends in harm reduction. Please watch our short video and read our article highlighting these trends!

Oct 16, 2015
István Gábor Takács
Scientists at the University of Debrecen, Hungary, are aiming to work on cutting-edge research to study how endogenous DMT, occurring naturally in the body, may be useful to modern medicine, particularly by protecting brain cells in the stage of clinical death.

Oct 13, 2015
István Gábor Takács
Well-targeted advocacy, hand-in-hand with a bit of hype, recently caused Serbian media to give extensive coverage to the idea of opening safe injecting rooms in the country. Part of the ‘Room for Change’ campaign in Serbia – read our local partner’s report!

Oct 12, 2015
Péter Sárosi
Our new movie provides an insight into the state of harm reduction in Eastern Europe: A struggle for survival in a time of economic austerity.

Oct 8, 2015
István Gábor Takács
In Poland, a ban on over a hundred new psychoactive substances coincided with a massive outbreak of poisonings related to the use of synthetic cannabinoids. The most pressing question must therefore be: Does an increase in prohibition do anything useful to protect our young people?


©